Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin

Abstract Background Trabectedin (Tbt) is an alkylating agent prescribed for soft tissue sarcomas after treatment failure of first line agents. While cardiomyopathy can occur with Tbt treatment after anthracycline exposure, Tbt-induced fulminant myocardial cytotoxic injury in the setting of other sys...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Annie J. Tsay, Mohan Satish, Elizabeth Corley, Ashley Ezema, Neisha DeJesus, Stephen Wisely, Eileen McAleer, Chen Zhang, Su Yuan, Edwin Homan, Jennifer E. Liu, Jonathan W. Weinsaft, Sandra D’Angelo, Stephanie A. Feldman, Angel T. Chan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-10-01
Edice:	Cardio-Oncology
Témata:	Trabectedin Cardiotoxicity Cardio-oncology Chemotherapy Cancer Sarcoma
On-line přístup:	https://doi.org/10.1186/s40959-024-00257-7
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!